Liposomal ET-18-OCH3 induces cytochrome c-mediated apoptosis independently of CD95 (APO-1/Fas) signaling

Blood

Volumn 94, Issue 10, 1999, Pages 3583-3592

  Cuvillier, Olivier ^b   Mayhew, Eric ^b   Janoff, Andrew S ^b   Spiegel, Sarah ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CASPASE; CYTOCHROME C; EDELFOSINE; ETHER LIPID; FAS ANTIGEN; LIPOSOME;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; DRUG FORMULATION; ENZYME ACTIVATION; ENZYME RELEASE; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; MITOCHONDRION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0033570960     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v94.10.3583.422k31_3583_3592     Document Type: Article

References (72)

1. Daniel LW: Ether lipids in experimental cancer chemotherapy, in Hickman JA, Tritton RT (eds): Cancer Chemotherapy. Oxford, UK, Blackwell Scientific, 1993, p 146
2. Houlihan WJ, Lohmeyer M, Workman P, Cheon SH: Phospholipid antitumor agents. Med Res Rev 15:157, 1995
3. Brachwitz H, Vollgraf C: Analogs of alkyl-lysophospholipids: Chemistry, effects on the molecular level and their consequences for normal and malignant cells. Pharmacol Ther 66:39, 1995
4. Berdel WE, Fink U, Rastetter J: Clinical phase I pilot study of the alkyl lysophospholipid derivative ET-18-OCH3. Lipids 22:967, 1987
5. Andreesen R, Munder PG: Cell-destructive activity in serum of a tumor patient after infusion of alkyl lysophospholipid. J Natl Cancer Inst 70:623, 1983
6. Lohmeyer M, Bittman R: Antitumor ether lipids and alkylphosphocholines. Drugs Future 19:1021, 1994
7. Weinstein NJ: Liposomes in the diagnosis and treatment of cancer, in Ostro MJ (ed): Liposomes From Biophysics to Therapeutics. New York, NY, Marcel Dekker, 1987, p 277
8. Szoka FC, Tang M: Amphotericin B formulated in liposomes and lipid based systems: A review. J Liposome Res 3:363, 1993
9. Cowens JW, Creaven PJ, Greco WR, Brenner DE, Tung Y, Ostro M, Pilkiewicz F, Ginsberg R, Petrelli N: Initial clinical (phase I) trial of TLC D-99 (doxorubicin encapsulated in lipsomes). Cancer Res 53: 2796, 1993
10. Sharma A, Mayhew E, Straubinger RM: Antitumor effect of taxol-containing liposomes in a taxol-resistant murine tumor model. Cancer Res 53:5877, 1993
11. Vaage J, Donovan D, Mayhew E, Uster P, Woodle M: Therapy of mouse mammary carcinomas with vincristine and doxorubicin encapsulated in sterically stabilized liposomes. Int J Cancer 54:959, 1993
12. Papahadjopoulos D, Allen TM, Gabizon A, Mayhew E, Matthay K, Huang SK, Lee KD, Woodle MC, Lasic DD, Redemann C, Martin FJ: Sterically stabilized liposomes: Improvements in pharmacokinetics and antitumor therapeutic efficacity. Proc Natl Acad Sci USA 88:11460, 1991
13. Ahmad I, Filep JJ, Franklin JC, Janoff AS, Masters GR, Pattassery J, Peters A, Schupsky JJ, Zha Y, Mayhew E: Enhanced therapeutic effects of liposome-associated 1-O-octadecyl-2-O-methyl-sn-glycero-3-phosphocholine. Cancer Res 57:1915, 1997
14. Perkins WR, Dause RB, Li X, Franklin JC, Cabral-Lilly DJ, Zha Y, Dank EH, Mayhew E, Janoff AS: Combination of antitumor ether lipid with lipids of complementary molecular shape reduces its hemolytic activity. Biochim Biophys Acta 1327:61, 1997
15. Peters AC, Ahmad I, Janoff AS, Pushkareva MY, Mayhew E: Growth inhibitory effects of liposome-associated 1-O-octadecyl-2-O-methyl-sn-glycero-3-phosphocholine. Lipids 32:1045, 1997
16. Cooper MR: Novel noncytotoxicanticancer agents: Signal transduction inhibitors, in Perry MC (ed): American Society of Clinical Oncology 1998 Fall Educational Book. Philadelphia, PA. Saunders, 1998, p 118
17. Helfman DM, Barnes KC, Kinkade JM Jr, Vogler WR, Shoji M, Kuo JF: Phospholipid-sensitive Ca2+-dependent protein phosphorylation system in various types of leukemic cells from human patients and in human leukemic cell lines HL60 and K562, and its inhibition by alkyl-lysophospholipid. Cancer Res 43:2955, 1983
18. Daniel LW, Etkin LA, Morrison BT, Parker J, Morris-Natschke S, Surles JR, Piantadosi C: Ether lipids inhibit the effects of phorbol diester tumor promoters. Lipids 22:851, 1987
19. Seewald MJ, Olsen RA, Sehgal I, Melder DC, Modest EJ, Powis G: Inhibition of growth factor-dependent inositol phosphate Ca2+ signaling by antitumor ether lipid analogues. Cancer Res 50:4458, 1990
20. Powis G, Seewald MJ, Gratas C, Melder D, Riebow J, Modest EJ: Selective inhibition of phosphatidylinositol phospholipase C by cytotoxic ether lipid analogues. Cancer Res 52:2835, 1992
21. Wagner BA, Buettner GR, Burns CP: Increased generation of lipid-derived and ascorbate free radicals by L1210 cells exposed to the ether lipid edelfosine. Cancer Res 53:711, 1993
22. Boggs KP, Rock CO, Jackowski S: Lysophosphatidylcholine attenuates the cytotoxic effects of the antineoplastic phospholipid 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine. J Biol Chem 270:11612, 1995
23. Zhou X, Arthur G: 1-O-octadecyl-2-O-methylglycerophosphocholine inhibits protein kinase C-dependent phosphorylation of endogenous proteins in MCF-7 cells. Biochem J 324:897, 1997
24. Baburina I, Jackowski S: Apoptosis triggered by 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine is prevented by increased expression of CTP:phosphocholine cytidylyltransferase. J Biol Chem 273:2169, 1998
25. Wagner BA, Buettner GR, Oberley LW, Burns CP: Sensitivity of K562 and HL-60 cells to edelfosine, an ether lipid drug, correlates with production of reactive oxygen species. Cancer Res 58:2809, 1998
26. Kiss Z, Crilly KS: Alkyl lysophospholipids inhibit phorbol ester-stimulated phospholipase D activity and DNA synthesis in fibroblasts. FEES Lett 412:313, 1997
27. Diomede L, Colotta F, Piovani B, Re F, Modest EJ, Salmona M: Induction of apoptosis in human leukemic cells by the ether lipid 1-octadecyl-2-methyl-rac-glycero-3-phosphocholine. A possible basis for its selective action. Int J Cancer 53:124, 1993
28. Mollinedo F, Martinez-Dalmau R, Modolell M: Early and selective induction of apoptosis in human leukemic cells by the alkyl-lysophospholipid ET-18-OCH3. Biochem Biophys Res Commun 192:603, 1993
29. Diomede L, Piovani B, Re F, Principe P, Colotta F, Modest EJ, Salmona M: The induction of apoptosis is a common feature of the cytotoxic action of ether-linked glycerophospholipids in human leukemic cells. Int J Cancer 57:645, 1994
30. Mollinedo F, Fernandez-Luna JL, Gajate C, Martin-Martin B, Benito A, Martinez-Dalmau R, Modolell M: Selective induction of apoptosis in cancer cells by the ether lipid ET-18-OCH3 (Edelfosine): Molecular structure requirements, cellular uptake, and protection by Bcl-2 and Bcl-X(L). Cancer Res 57:1320, 1997
31. Kidd VJ: Proteolytic activities that mediate apoptosis. Annu Rev Physiol 60:533, 1998
32. Thornberry NA, Lazebnik Y: Caspases: Enemies within. Science 281:1312, 1998
33. Kroemer G, Dallaporta B, Resche-Rigon M: The mitochondrial death/life regulator in apoptosis and necrosis. Annu Rev Physiol 60:619, 1998
34. Green DR, Reed JC: Mitochondria and apoptosis. Science 281:1309, 1998
35. Zou H, Henzel WJ, Liu X, Lutschg A, Wang X: Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell 90:405, 1997
36. Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES, Wang X: Cytochrome c and dATP-dependent formation of Apaf-1/Caspase-9 complex initiates an apoptotic protease cascade. Cell 91:479, 1997
37. Srinivasula SM, Ahmad M, Fernandes-Alnemri T, Alnemri ES: Autoactivation of procaspase-9 by Apaf-1-mediated oligomerization. Mol Cell 1:949, 1998
38. Szoka FC, Papahadjopoulos D: Comparative properties and methods of preparation of lipid vesicles (liposomes). Annu Rev Biophys Bioeng 9:467, 1980
39. Cuvillier O, Rosenthal DS, Smulson ME, Spiegel S: Sphingosine 1-Phosphate inhibits activation of caspases that cleave Poly(ADP-ribose) Polymerase and lamins during Fas-and ceramide-mediated apoptosis in Jurkat T lymphocytes. J Biol Chem 273:2910, 1998
40. Nicholson DW, All A, Thornberry NA, Vaillancourt JP, Ding CK, Gallant M, Gareau Y, Griffin PR, Labelle M, Lazebnik YA, Munday NA, Raju SM, Smulson ME, Yamin T, Yu VL, Miller DK: Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 376:37, 1995
41. Tewari M, Quan LT, O'Rourke K, Desnoyers S, Zeng Z, Beidler DR, Poirier GG, Salvesen GS, Dixit VM: Yama/CPP32β, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate Poly(ADP-ribose) polymerase. Cell 81:801, 1995
42. Fernandes-Alnemri T, Litwak G, Alnemri ES: CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein Ced-3 and mammalian interleukin-1β-converting enzyme. J Biol Chem 269:30761, 1994
43. Chinnaiyan AM, Orth K, O'Rourke K, Duan H, Poirier GG, Dixit VM: Molecular ordering of the cell death pathway. Bcl-2 and Bcl-xL function upstream of the CED-3-like apoptotic proteases. J Biol Chem 271:4573, 1996
44. Duan H, Chinnaiyan AM, Hudson PL, Wing JP, He W, Dixit VM: ICE-LAP3, a novel mammalian homologue of the Caenorhabditis elegans cell death protein Ced-3 is activated during Fas-and tumor necrosis factor-induced apoptosis. J Biol Chem 271:1621, 1996
45. Chao DT, Korsmeyer SJ: BCL-2 family: Regulators of cell death. Annu Rev Immunol 16:395, 1998
46. Adams JM, Cory S: The Bcl-2 protein family: Arbiters of cell survival. Science 281:322, 1998
47. Srinivasula SM, Fernandes-Alnemri T, Zangrilli J, Robertson N, Armstrong RC, Wang L, Trapani JA, Tomaselli KJ, Litwack G, Alnemri ES: The CED-3/interleukin 1β converting enzyme-like homolog Mch6 and the lamin-cleaving enzyme Mch2α are substrates for the apoptotic mediator CPP32. J Biol Chem 271:27099, 1996
48. Lazebnik YA, Takahashi A, Moir RD, Goldman RD, Poirier GG, Kaufman SH, Earnshaw WC: Studies of the lamin proteinase reveal multiple biochemical pathways during apoptotic execution. Proc Natl Acad Sei USA 92:9042, 1995
49. Thornberry NA, Rano TA, Peterson EP, Rasper DM, Timkey T, Garcia-Calvo M, Houtzager VM, Nordstrom PA, Roy S, Vaillancourt JP, Chapman KT, Nicholson DW: A combinatorial approach defines specificities of members of the caspase family and granzyme B. Functional relationships established for key mediators of apoptosis. J Biol Chem 272:17907, 1997
50. Li H, Bergeron L, Cryns V, Pasternack MS, Zhu H, Shi L, Greenberg A, Yuan J: Activation of caspase-2 in apoptosis. J Biol Chem 272:21010, 1997
51. Slee EA, Harte MT, Kluck RM, Wolf BB, Casiano CA, Newmeyer DD, Wang HG, Reed JC, Nicholson DW, Alnemri ES, Green DR, Martin SJ: Ordering the cytochrome c-initiated caspase cascade: Hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner. J Cell Biol 144:281, 1999
52. Peter ME, Krammer PH: Mechanisms of CD95 (APO-1/Fas)-mediated apoptosis. Curr Opin Immunol 10:545, 1998
53. Scaffidi C, Fulda S, Srinivasan A, Friesen C, Li F, Tomaselli KJ, Debatin KM, Krammer PH, Peter ME: Two CD95 (APO-1/Fas) signaling pathways. EMBO J 17:1675, 1998
54. Scaffidi C, Medema JP, Krammer PH, Peter ME: FLICE is predominantly expressed as two functionally active isoforms, caspase-8/a and caspase-8/b. J Biol Chem 272:26953, 1997
55. Fernandes-Alnemri T, Armstrong RC, Krebs J, Srinivasula SM, Wang L, Bullrich F, Fritz LC, Trapani JA, Tomaselli KJ, Litwack G, Alnemri ES: In vitro activation of CPP32 and Mch3 by Mch4, a novel human apoptotic cysteine protease containing two FADD-like domains. Proc Natl Acad Sci USA 93:7464, 1996
56. Vincenz C, Dixit V: Fas-associated death domain protein interleukin-1β-converting enzyme2 (FLICE2), an ICE/Ced-3 homologue, is proximally involved in CD95-and p55-mediated death signaling. J Biol Chem 272:6578, 1997
57. Li H, Zhu H, Xu CJ, Yuan J: Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 94:491, 1998
58. Luo X, Budihardjo I, Zou H, Slaughter C, Wang X: Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 94:481, 1998
59. Gross A, Yin XM, Wang K, Wei MC, Jockel J, Milliman C, Erdjument-Bromage H, Tempst P, Korsmeyer SJ: Caspase cleaved BID targets mitochondria and is required for cytochrome c release, while BCL-XL prevents this release but not tumor necrosis factor-R1/Fas death. J Biol Chem 274:1156, 1999
60. Sun XM, MacFarlane M, Zhuang J, Wolf BB, Green DR, Cohen GM: Distinct caspase cascades are initiated in receptor-mediated and chemical-induced apoptosis. J Biol Chem 274:5053, 1999
61. Green D, Kroemer G: The central executioners of apoptosis: Caspases or mitochondria? Trends Cell Biol 8:267, 1998
62. Debatin KM, Beltinger C, Bohler T, Fellenberg J, Friesen C, Fulda S, Herr I, Los M, Scheuerpflug C, Sieverts H, Stahnke K: Regulation of apoptosis through CD95 (APO-1/Fas) receptor-ligand interaction. Biochem Soc Trans 25:405, 1997
63. Friesen C, Herr I, Krammer PH, Debatin KM: Involvement of the CD95 (APO-1/FAS) receptor/ligand system in drug-induced apoptosis in leukemia cells. Nat Med 2:574, 1996
64. Herr I, Wilhelm D, Bohler T, Angel P, Debatin K: Activation of CD95 (APO-1/Fas) signaling by ceramide mediates cancer therapy-induced apoptosis. EMBO J 16:6200, 1997
65. Friesen C, Fulda S, Debatin KM: Deficient activation of the CD95 (APO-1/Fas) system in drug-resistant cells. Leukemia 11:1833, 1997
66. Fulda S, Scaffidi C, Pietsch T, Krammer PH, Peter ME, Debatin K-M: Activation of the CD-95 (APO-1/Fas) pathway in drug-and γ-irradiation-induced apoptosis of brain tumor cells. Cell Death Diff 5:884, 1998
67. Hug H, Strand S, Grambihler A, Galle J, Hack V, Stremmel W, Krammer PH, Galle PR: Reactive oxygen intermediates are involved in the induction of CD95 ligand mRNA expression by cytostatic drugs in hepatoma cells. J Biol Chem 272:28191, 1997
68. Müller M, Strand S, Hug H, Heinemann EM, Walczak H, Hofmann WJ, Stremmel W, Krammer PH, Galle PR: Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53. J Clin Invest 99:403, 1997
69. Fulda S, Sieverts H, Friesen C, Herr I, Debatin KM: The CD95 (APO-1/Fas) system mediates drug-induced apoptosis in neuroblastoma cells. Cancer Res 57:3823, 1997
70. Han Z, Bhalla K, Pantazis P, Hendrickson EA, Wyche JH: Cif (Cytochrome c efflux-inducing factor) activity is regulated by bcl-2 and caspases and correlates with the activation of Bid. Mol Cell Biol 19:1381, 1999
71. Chauhan D, Pandey P. Ogata A, Teoh G, Krett N, Halgren R, Rosen S, Kufe D, Kharbanda S, Anderson K: Cytochrome c-dependent and -independent induction of apoptosis in multiple myeloma cells. J Biol Chem 272:29995, 1997
72. Tang DG, Li L, Zhu Z, Joshi B: Apoptosis in the absence of cytochrome c accumulation in the cytosol. Biochem Biophys Res Commun 242:380, 1998